Sign In
Buy ABBV
$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
AbbVie's Allergan reaches $2 billion opioid lawsuit settlement - Bloomberg News
06:18pm, Wednesday, 27'th Jul 2022
AbbVie Inc's unit Allergan has reached an agreement to pay over $2 billion to resolve thousands of lawsuits related to the marketing of its opioid painkiller, Bloomberg News reported on Wednesday, cit
7 Blue-Chip Stocks to Buy on the Dip
10:22am, Wednesday, 27'th Jul 2022
Let's first define the dip. The S&P 500 is currently down 17.83% year-to-date.
3 Dividend Kings Suited Perfectly for Income Investors
04:16pm, Monday, 25'th Jul 2022
Meeting the parameters to join the elite Dividend King group speaks volumes about these companies' well-established and thriving nature.
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
10:03am, Monday, 25'th Jul 2022
Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.
AbbVie and Allergan Aesthetics to Present New Data from Leading Neurotoxin Portfolio at TOXINS 2022 Conference
08:00am, Monday, 25'th Jul 2022
– Data analyses of onabotulinumtoxinA (BOTOX ® ) in adult patients with chronic migraine, cervical dystonia, overactive bladder, spasticity, and pediatric patients with neurogenic detrusor overacti
My Top 3 Picks For 2022 Revisited: 2 Huge Winners, But Google Falters
03:11am, Monday, 25'th Jul 2022
It's time to revisit these top picks as we are more than halfway through a tumultuous 2022. AbbVie and VICI have vastly outperformed the market, but Alphabet is struggling.
7 Value Stocks Trading at a Massive Discount Right Now
09:35am, Sunday, 24'th Jul 2022
These value stocks trading at discount are trading at attractive valuations while their fundamentals continue to impress. The post 7 Value Stocks Trading at a Massive Discount Right Now appeared first
2nd-Quarter Earnings Results Could Impact Drug Company Shares
04:58pm, Friday, 22'nd Jul 2022
The second-quarter earnings season is upon us, and the news coming out of several members of Big Pharma could potentially shake up their share prices. Beyond that, several unknowns could impact top-ti
AbbVie (ABBV) Reports Next Week: Wall Street Expects Earnings Growth
11:44am, Friday, 22'nd Jul 2022
AbbVie (ABBV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Could AbbVie Stock Help You Retire a Millionaire?
11:00am, Friday, 22'nd Jul 2022
The healthcare company has been outperforming the S&P over the past decade by a wide margin.
Healthcare ETFs in Focus Ahead of Q2 Earnings
01:14pm, Thursday, 21'st Jul 2022
The healthcare sector has gained some momentum lately on investors' rush to safety in a volatile stock market. The sector is non-cyclical in nature, which in turn, is providing a cushion to the portfo
3 High Yield Dividend Stocks To Watch Today
04:10pm, Wednesday, 20'th Jul 2022
Do you have these top high-yield dividend stocks on your watchlist right now?
7 Best Income Stocks to Buy Now
06:15am, Wednesday, 20'th Jul 2022
With inflation putting a beating on household budgets and earnings, the best income stocks to buy may help mitigate the crisis. The post 7 Best Income Stocks to Buy Now appeared first on InvestorPlace
A Dose of AbbVie Stock Can Help Your Bear Market Portfolio
01:00am, Wednesday, 20'th Jul 2022
AbbVie (NYSE: ABBV) is a conventional stock for unconventional times. And that's exactly why it makes sense to add or hold in your bear market portfolio.
3 Dividend Growth Stocks You Can Buy Now and Hold Forever
05:13am, Tuesday, 19'th Jul 2022
Recession or no recession, these well-established businesses are going to keep on growing.
